The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2020
Filed:
Sep. 29, 2015
Applicant:
The Trustees of Columbia University IN the City of New York, New York, NY (US);
Inventors:
Ramin Parsey, Mountain Lakes, NJ (US);
Arthur Mikhno, New City, NY (US);
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); A61B 5/16 (2006.01); A61B 5/055 (2006.01); A61B 6/03 (2006.01); A61B 6/00 (2006.01); G01R 33/00 (2006.01); G01R 33/10 (2006.01); A61B 5/00 (2006.01); G06T 7/41 (2017.01); G06K 9/52 (2006.01); G06K 9/62 (2006.01); G01R 33/48 (2006.01); G06K 9/46 (2006.01);
U.S. Cl.
CPC ...
G06T 7/0014 (2013.01); A61B 5/0042 (2013.01); A61B 5/055 (2013.01); A61B 5/165 (2013.01); A61B 5/4088 (2013.01); A61B 5/7275 (2013.01); A61B 6/037 (2013.01); A61B 6/501 (2013.01); A61B 6/5247 (2013.01); A61B 6/56 (2013.01); A61B 6/563 (2013.01); G01R 33/0023 (2013.01); G01R 33/10 (2013.01); G01R 33/481 (2013.01); G06K 9/52 (2013.01); G06K 9/6267 (2013.01); G06T 7/0012 (2013.01); G06T 7/0016 (2013.01); G06T 7/41 (2017.01); G06K 2009/4666 (2013.01); G06T 2200/04 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/10104 (2013.01); G06T 2207/20021 (2013.01); G06T 2207/20076 (2013.01); G06T 2207/20128 (2013.01); G06T 2207/30016 (2013.01);
Abstract
The subject matter disclosed herein relates to methods for diagnosing a neurological disorder in a subject. In certain aspects, the methods described herein involve determining one or more critical areas in the brain from molecular Magnetic Resonance Imaging (MRI) data where two groups differ and measuring MRI signal within determined critical areas in a new subject in order to assign risk or diagnosis.